MediTask, sro

Bratislava 83103

1 studies enrolling now · 4 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 2, Obesity, Overweight

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) — Completed
• A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed